Long Vien
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Phagocytosis and Immune Regulation, Protease and Inhibitor Mechanisms, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation(2004)306 cited
- → Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouse(1998)238 cited
- → Modulation of Notch Signaling by Antibodies Specific for the Extracellular Negative Regulatory Region of NOTCH3(2008)196 cited
- → Antibodies Targeting Human OX40 Expand Effector T Cells and Block Inducible and Natural Regulatory T Cell Function(2013)91 cited
- → Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer(2019)73 cited
- → Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death(2022)33 cited
- → B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade(2022)22 cited
- → Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas(2023)14 cited
- → Monoclonal Antibodies Generation: Updates and Protocols on Hybridoma Technology(2022)10 cited
- → Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells(2014)9 cited